Timely Insights for Healthcare Experts
Onward and Down 2019: Medical Cost Trends and Pharmacy-Led Strategies to Mitigate Them
Healthcare reform and improvement has entered exciting times. Medical R&D and health informatics (HIT) are growing at a rapid rate, offering better options to a more curious and proactive generation of consumers. More regulatory bodies and...
read more
Untapped Support: Certified Pharmacy Technicians for More Efficient Pharmacies
Today’s healthcare industry is a race between technology, policy, and support, with the endpoint for all of them being a more patient-centered approach. Technological advancements have made precision medicine possible, resulting in an explosion of data and...
read more
Keep Your Genes On: How to Set Patients’ Expectations of PGx Testing
Moving Forward with Proper PGx Expectations 2,5Pharmacogenomic (PGx) testing and PGx-based treatments may be all the rage in precision medicine today, but more genetic and pharmacology experts – especially in the areas of cardiology, pain management, and...
read more
Expanding Services and Savings: Why Leveraging a Remote Pharmacy is a Win-Win
Moving Forward with Remote SupportThe intimidating costs behind patient-centered healthcare reform can be mitigated with the added revenue and reduced labor costs of establishing remote pharmacy models (RPMs). These highly efficient sites not only give...
read more
Trump Signs Opioid Law; Pharmacists Still Frustrated with Lack of Medicare B Coverage
Moving Forward with New Provisions The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act (H.R. 6), signed on October 24, 2018, addresses the opioid crisis by reducing supply and access...
read more
Getting a Bigger Slice of the P.I.E.: The Pharmacist’s Duties in Clinical Pharmacogenomics (PGx)
Getting a Bigger Slice of the P.I.E.: The Pharmacist’s Duties in Clinical Pharmacogenomics (PGx) Ninety percent of Americans live within 5 miles of a community pharmacy, with local patients averaging 35 drugstore visits annually. Compared to the average...
read more
PGx + CDSS: Completing the Formula for Expanded Affordable Quality Healthcare
Pharmacogenomics (PGx) is rapidly evolving from being a “luxury” diagnostic test to the healthcare standard millions of patients and providers have been waiting for. Although PGx is a relatively new field, the R&D support and buzz behind it is growing...
read more
Patient-Centered Care & Barriers to Adherence
While medical R&D has been making great strides in precision medicine and pharmacogenetics – ultimately tailoring diagnostics and treatments to match individuals on a submolecular level – healthcare providers need to remember that their relationships...
read more
Association Of Exercise With Mortality In Adults Who Survived Childhood Cancer
A recent study of adults who survived childhood cancer revealed increased exercise (with a mean of 7.9 Metabolic Equivalent Task) over eight years was associated with 40% reduction in all-cause mortality rate when compared to low maintenance of...
read more
CMS Reshapes and Finalizes “Promoting Interoperability” Rule as Providers Transition to Stage 3 in 2019
Following the Centers for Medicare & Medicaid Services’ (CMS) April 2018 rule proposal comes the finalization of the “Promoting Interoperability” rule (PI, formerly known as the Meaningful Use program). CMS hopes that by reshaping the rule to be more concise and...
read more
Annual World Breastfeeding Week and the Benefits of Breastfeeding
August kicks off with World Breastfeeding Week, now on its 27th year since it was first celebrated by the World Alliance for Breastfeeding Action (WABA) in 1992. Every August 1-7, WABA partners with a worldwide network of organizations to encourage...
read more
FDA Grants Approval for First Targeted Anticancer Treatment for Relapsed or Refractory Acute Myeloid Leukemia with IDH1 Mutation
On July 20, 2018, the U.S. Food and Drug Administration (FDA) approved the first acute myeloid leukemia treatment. It is the first approved targeted cancer therapy for patients with relapsed or refractory acute myeloid leukemia (R/R AML), specifically,...
read morePEPID Announces its Participation in the 2018 ACEP Scientific Assembly
Phoenix, AZ, USA, August 1, 2018 — Medical information and clinical solutions developer, PEPID, LLC, will attend the largest emergency medicine (EM) convention in the country. The annual American College of Emergency Physicians (ACEP) Scientific Assembly will take...
read more
What you need to know about Herbal-Drug Interactions
Evidence that Adverse Drug Interactions Occur from Herbal-Drug Interactions and Non-Prescription Drug Interactions. “Natural” is widely perceived by the public to ensure safety. However, studies show drug interactions with active pharmaceutical agents, and...
read more
Suicide Rates Rising in the United States
U.S. Suicide Rates Rising: Now the 10th Leading Cause of Death Over the past 19 years, U.S. suicide rates have increased in every state except Nevada. Suicide now stands as the tenth overall leading cause of death in the United States. Suicide was the...
read more
WHO Just Released ICD-11: 5 Notable Changes
The World Health Organization has released the 11th edition of the International Classification of Diseases (ICD-11). Here are a few of the notable changes. ICD-11 is completely electronic with 40,600 more codes for injuries, diseases and cause of death than ICD-10....
read more
New CRC Screening Guidelines
According to the new crc screening guidelines the American Cancer Society (ACS) released May 30, colorectal cancer screening should begin at 45 years old rather than 50. (4) Colorectal cancer (CRC) is the fourth most common cancer diagnosed among adults in the United...
read more
First FDA approved CGRP Blocking Migraine Prevention Med
The first migraine prevention medication was approved by the FDA in May, 2018. Pharmaceutical companies Amgen and Novartis designed the CGRP receptor blocking monthly injection Aimovig (erenumab-aooe) as a game changer for those who suffer from migraines. Aimovig is...
read more
The Predicted Effects of New Hypertension Guidelines
It has been six months since ACC/AHA changed the hypertension(HTN) guidelines, effectively reclassifying 31 million more US adults from ‘high or elevated blood pressure’ to HTN. The new hypertension guidelines define HTN Stage 1 as systolic from 130-139 or HG...
read more